Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adelheid Cerwenka

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
The Journal of Experimental Medicine|February 11, 2009
New twist on the regulation of NKG2D ligand expressionAdelheid Cerwenka
Immunobiology|August 13, 2015
Tricking the balance: NK cells in anti-cancer immunityJens Pahl, Adelheid Cerwenka
Nature Immunology|June 20, 2018
Checkpoint inhibition: NK cells enter the sceneAna Stojanovic, Adelheid Cerwenka
Immunity|October 13, 2021
ILC1-like NK cells as matchmakers for DC-T cell interactionsAna Stojanovic, Adelheid Cerwenka
Cancer Cell|August 27, 2021
An intimate encounter: DC3s empower anti-tumor CTLsAna Stojanovic, Adelheid Cerwenka
Cancer Discovery|April 6, 2016
STAT5 Loss Awakens the Dark Force in Natural Killer CellsJing Ni, Adelheid Cerwenka
Science (New York, N.Y.)|April 4, 2015
Immunology. MULT1plying cancer immunityAlexander Steinle, Adelheid Cerwenka
Journal of Innate Immunity|April 20, 2011
Natural killer cells and solid tumorsAna Stojanovic, Adelheid Cerwenka
Science (New York, N.Y.)|March 31, 2018
Natural killers join the fight against cancerAdelheid Cerwenka, Lewis L Lanier
Immunology Letters|January 15, 2008
The TREM-1/DAP12 pathwayAnja S Tessarz, Adelheid Cerwenka
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
The Journal of Experimental Medicine|February 11, 2009
New twist on the regulation of NKG2D ligand expressionAdelheid Cerwenka
Immunobiology|August 13, 2015
Tricking the balance: NK cells in anti-cancer immunityJens Pahl, Adelheid Cerwenka
Nature Immunology|June 20, 2018
Checkpoint inhibition: NK cells enter the sceneAna Stojanovic, Adelheid Cerwenka
Immunity|October 13, 2021
ILC1-like NK cells as matchmakers for DC-T cell interactionsAna Stojanovic, Adelheid Cerwenka
Cancer Cell|August 27, 2021
An intimate encounter: DC3s empower anti-tumor CTLsAna Stojanovic, Adelheid Cerwenka
Cancer Discovery|April 6, 2016
STAT5 Loss Awakens the Dark Force in Natural Killer CellsJing Ni, Adelheid Cerwenka
Science (New York, N.Y.)|April 4, 2015
Immunology. MULT1plying cancer immunityAlexander Steinle, Adelheid Cerwenka
Journal of Innate Immunity|April 20, 2011
Natural killer cells and solid tumorsAna Stojanovic, Adelheid Cerwenka
Science (New York, N.Y.)|March 31, 2018
Natural killers join the fight against cancerAdelheid Cerwenka, Lewis L Lanier
Immunology Letters|January 15, 2008
The TREM-1/DAP12 pathwayAnja S Tessarz, Adelheid Cerwenka
Pageof 11